GBP1
Basic information
Region (hg38): 1:89051882-89065360
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GBP1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 46 | 53 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 46 | 9 | 0 |
Variants in GBP1
This is a list of pathogenic ClinVar variants found in the GBP1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-89053377-C-T | not specified | Uncertain significance (Jun 17, 2024) | ||
1-89053386-A-G | not specified | Uncertain significance (Jun 16, 2023) | ||
1-89053413-T-G | not specified | Uncertain significance (Jun 18, 2021) | ||
1-89053459-G-T | not specified | Uncertain significance (Sep 03, 2024) | ||
1-89054646-GAAAAAC-G | Neutrophil inclusion bodies | Likely pathogenic (-) | ||
1-89054701-G-T | not specified | Uncertain significance (Jun 16, 2024) | ||
1-89054717-T-C | not specified | Likely benign (Aug 13, 2021) | ||
1-89054722-A-G | Likely benign (Jan 01, 2025) | |||
1-89054737-T-C | not specified | Uncertain significance (Jun 11, 2024) | ||
1-89054824-T-C | not specified | Uncertain significance (May 06, 2022) | ||
1-89054831-A-C | not specified | Uncertain significance (Jul 02, 2024) | ||
1-89054855-A-T | not specified | Uncertain significance (Jan 29, 2024) | ||
1-89055205-A-G | not specified | Uncertain significance (Aug 10, 2021) | ||
1-89056021-T-C | not specified | Uncertain significance (Aug 15, 2023) | ||
1-89056045-A-G | not specified | Uncertain significance (Aug 04, 2024) | ||
1-89056075-C-T | not specified | Likely benign (Jan 10, 2022) | ||
1-89056089-C-T | not specified | Uncertain significance (Apr 28, 2022) | ||
1-89056090-C-G | not specified | Uncertain significance (Jun 24, 2022) | ||
1-89056155-A-G | not specified | Uncertain significance (Jan 19, 2024) | ||
1-89056209-C-T | not specified | Uncertain significance (Mar 14, 2024) | ||
1-89056212-T-C | not specified | Uncertain significance (Mar 06, 2023) | ||
1-89056217-T-G | not specified | Likely benign (Jan 17, 2023) | ||
1-89056855-G-A | not specified | Uncertain significance (Feb 27, 2023) | ||
1-89056936-C-G | not specified | Uncertain significance (Mar 27, 2023) | ||
1-89057000-G-C | not specified | Uncertain significance (Mar 21, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GBP1 | protein_coding | protein_coding | ENST00000370473 | 10 | 13042 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.26e-15 | 0.0423 | 125417 | 1 | 330 | 125748 | 0.00132 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.452 | 338 | 315 | 1.07 | 0.0000170 | 3898 |
Missense in Polyphen | 137 | 137.69 | 0.99497 | 1832 | ||
Synonymous | -1.05 | 137 | 122 | 1.12 | 0.00000683 | 1096 |
Loss of Function | 0.608 | 25 | 28.5 | 0.877 | 0.00000149 | 333 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00538 | 0.00538 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00652 | 0.00644 |
Finnish | 0.000185 | 0.000185 |
European (Non-Finnish) | 0.000722 | 0.000703 |
Middle Eastern | 0.00652 | 0.00644 |
South Asian | 0.000163 | 0.000163 |
Other | 0.000653 | 0.000652 |
dbNSFP
Source:
- Function
- FUNCTION: Hydrolyzes GTP to GMP in 2 consecutive cleavage reactions. Exhibits antiviral activity against influenza virus. Promote oxidative killing and deliver antimicrobial peptides to autophagolysosomes, providing broad host protection against different pathogen classes. {ECO:0000269|PubMed:22106366}.;
- Pathway
- NOD-like receptor signaling pathway - Homo sapiens (human);Type II interferon signaling (IFNG);Cytokine Signaling in Immune system;Immune System;Interferon gamma signaling;Interferon Signaling
(Consensus)
Recessive Scores
- pRec
- 0.173
Intolerance Scores
- loftool
- 0.958
- rvis_EVS
- -0.08
- rvis_percentile_EVS
- 47.2
Haploinsufficiency Scores
- pHI
- 0.514
- hipred
- N
- hipred_score
- 0.252
- ghis
- 0.384
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.287
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- regulation of calcium-mediated signaling;negative regulation of T cell receptor signaling pathway;protein homooligomerization;defense response to virus;interferon-gamma-mediated signaling pathway;negative regulation of ERK1 and ERK2 cascade;cellular response to interferon-gamma;cellular response to interleukin-1;cellular response to tumor necrosis factor;protein localization to vacuole;negative regulation of substrate adhesion-dependent cell spreading;negative regulation of interleukin-2 secretion;regulation of protein localization to plasma membrane;negative regulation of protein localization to plasma membrane
- Cellular component
- Golgi membrane;extracellular region;cytoplasm;Golgi apparatus;cytosol;plasma membrane;vesicle membrane;actin cytoskeleton
- Molecular function
- actin binding;GTPase activity;protein binding;GTP binding;GDP binding;enzyme binding;cytokine binding;spectrin binding;identical protein binding;protein homodimerization activity;Hsp90 protein binding